MedTrace Logo

A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients

NCT01672762 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2024-11-08

No results posted yet for this study

Summary

This study is to evaluate safety and efficacy of ASP1941 after 24 week administration to diabetic patients.

Conditions

Interventions

DRUG

ipragliflozin

oral

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Medical Director · Astellas Pharma Inc

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-25
Primary Completion
2013-04-13
Completion
2013-04-13

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01672762 on ClinicalTrials.gov